Background Psychological illness occurring in association with hyperemesis gravidarum (HG) has been widely reported.
Introduction
Nausea or vomiting in pregnancy (NVP) are experienced by up to 91% of women. 1, 2 For some, these symptoms are excessive, resulting in ketonuria, dehydration and weight loss, leading to hospital admission. This condition is termed hyperemesis gravidarum (HG) and is a diagnosis of exclusion. The reported incidence of 0.3-2% varies across ethnic groups and is dependent on diagnostic criteria. 1, 3 HG is one of the most common reasons for antenatal admission, which is often repeated and prolonged. 4 Many individual aetiological theories underlying HG have been proposed, including hormonal, immunological, infective and genetic factors. 3, [5] [6] [7] [8] [9] It is generally agreed that the condition is multifactorial and as yet not fully understood. 10 Psychological illness has been reported as both a complication of, and predisposing factor for, HG and there remains a debate regarding the direction of association. This link is long standing; in 1971 Uddenberg et al. found an association between increasing severity of nausea and vomiting of pregnancy and mental health symptoms both during and after the pregnancy. 11 Psychological theories include HG as a conversion disorder or a result of conditioning. 12 However, methodological flaws in studies reporting psychological illness as a cause of HG have left this concept unsupported by evidence. 13 It is plausible that prepregnancy mental health symptoms such as anxiety and depression alter the perception of physical symptoms or exacerbate their absolute severity. The latter theory has been demonstrated in patients receiving chemotherapy. 14 The management of HG and NVP, both in primary and secondary care, is primarily focused on physical supportive therapy, 15 whereas the assessment of psychological illness and provision of psychological support to affected women is less well established. Depression, anxiety, post-traumatic stress disorder (PTSD) and maternal-fetal attachment have all been studied in relation to HG and it is considered that the true psychological impact of suffering of HG is significantly underestimated. 16 We present the results of a systematic review and meta-analyses of case-control studies investigating the psychological associations with HG.
Methodology

Criteria for considering studies for this review
The psychological illnesses included in the review were mood disorders (depression), anxiety disorders (generalised anxiety disorder, panic disorder, specific phobia, social phobia) and PTSD. No language restrictions were applied. Non-English (Spanish, German, Italian, French and Turkish) articles were reviewed and translated to allow analysis. Both case-control and cohort study designs were included in the systematic review but only case-control studies were used for meta-analysis. Online publications were included. Case reports were not included.
Search methods and eligibility criteria
The systematic review and meta-analysis were performed and reported in accordance with recommended methods, using the PRISMA checklist. 17 We searched the electronic databases MEDLINE, Embase and PsychINFO via the platform OvidSP to identify suitable articles assessing psychological symptoms in relation to HG published between January 1980 and September 2015. The MeSH (medical subject headings) used as search criteria were; 'hyperemesis gravidarum', 'pregnancy vomiting', 'morning sickness', 'psychological impact', 'mental health', 'psychological', 'psychological wellbeing', 'anxiety', 'anxiety disorder', 'depression' and 'posttraumatic stress disorder'. The two concepts were first expanded with the Boolean operator 'or' then linked together using 'and'. A PubMed search was also performed using the search criteria 'hyperemesis gravidarum depression', 'hyperemesis gravidarum anxiety' and 'hyperemesis gravidarum post-traumatic stress disorder'. The reference lists and crossreferences of eligible studies were searched.
We applied the following criteria to select eligible articles for meta-analysis: 1 articles referring to psychological morbidity in relation to hyperemesis gravidarum 2 case-control design 3 use of numerical scales to compare psychological symptoms 4 assessment of at least one of: mood disorders, anxiety disorders or post-traumatic stress disorder 5 published results which included the mean scale score for each group plus standard deviations (or ability to calculate these from other results).
Data collection
Articles were independently assessed by two reviewers (NMJ and JF). After identification and abstract review, full versions of the selected articles were extracted. The following information was obtained and tabulated: author's name, year of publication, type of psychological illness/ symptom assessed, method of assessment, number and timing of assessments, incidence of psychological illness in the HG group at each assessment and incidence of psychological illness in the control group at each assessment. Where data were not extractable from the paper the corresponding author was contacted directly. Any other findings thought to be significant were also recorded.
Quality assessment of studies
Three reviewers (NMJ, JF and CB) assessed the study methodology using the Newcastle-Ottawa assessment scale for observational studies. 18 Differences of opinion were discussed and the consensus opinion was taken. The Newcastle-Ottawa assessment scale assesses methodology in three areas: selection, comparability and exposure. The highest quality studies are awarded up to nine stars. Studies that scored the maximum of four stars for the selection criteria, two stars for comparability criteria and three stars for exposure criteria were considered to have a low risk of bias. Studies with two or three stars for selection, one for comparability and two for exposure were deemed to have a medium risk of bias. Any study with a score of one for selection or exposure, or zero for any of the three domains, was deemed to have a high risk of bias.
Selection of cases (maximum score four stars) As there is no standardised definition of HG, we assessed the inclusion criteria for each paper looking for the use of objective diagnostic criteria such as a symptom scoring system, e.g. PUQE (Pregnancy Unique Quantification of Emesis 19 ), weight loss or ketonuria. Admission to hospital alone was not considered adequate case definition unless specific admission criteria were given. To assess representativeness, we looked for attempts to recruit consecutive cases, or recruit women over a fixed time period.
Studies where the source or method of recruitment of patients for the control group was not clear were not considered adequate. Merit (a star) was awarded where controls were outpatient or community controls (for example recruited from routine antenatal clinics). Self-reporting the absence of significant NVP was accepted as adequate, as was the use of symptom assessment scales, such as the Rhodes criteria. 20 Comparability of cases and controls (maximum score two stars) Parity, gestation, ethnicity, age, body mass index (BMI) and socio-economic group were considered the most important variables in comparing the case and control groups. One star was awarded to studies where there was a comparison of at least three of these variables. A further star was awarded if the analysis was adjusted to allow for any identified significant difference in these variables or if there was no significant difference in these variables between groups.
Exposure criteria (maximum score three stars) Independent validation of exposure was considered to be the diagnosis of HG by a physician rather than self-reporting of symptoms. Merit was awarded if assessment type and timing were the same for cases and controls and where nonresponse rates were quoted for both groups.
Data synthesis and statistical analysis
Depression and anxiety scale scores for both groups (HG and controls) were compared by standardised mean differences (SMD). The SMD is the difference in mean effects in the experimental and control groups divided by the pooled standard deviation of participants' outcomes. This summary statistic is used when the studies all assess the same outcome but measure it in a variety of ways (for example measuring depression using different psychometric scales). 21 Standardised mean differences from individual studies were meta-analysed using the random effects model. 21 The SMDs have been described in categorical terms of magnitude of effect, using the widely accepted guideline of Cohen, 22 which defines an SMD of 0.2 as small, 0.5 as medium and 0.8 or more as a large effect. We also transformed the pooled SMD to an odds ratio (OR) for easier clinical interpretation. 21 This transformation is based on the reasonable assumption that the underlying continuous scores have a logistic distribution with equal standard deviation in the two groups, but this may not hold exactly and it represents an approximation. 21 For studies that did not adjust for independent variables, we planned a priori subgroup analyses for important confounders that include parity, gestation, ethnicity, age, BMI and socio-economic group. Heterogeneity between studies was assessed graphically by Forest plots and statistically by performing a chi-square test, with a P-value <0.1 suggesting significant heterogeneity and calculating the I 2 parameter. Statistical analyses were performed using REV-MAN 5.0 (Cochrane Collaboration, Oxford, UK).
Results
Search results
The search strategy initially yielded 589 studies. After removing 536 studies (186 duplicates and 350 not eligible after review of abstracts) we then identified six further potentially eligible studies after manual checking of the citation lists. Fifty-nine articles were therefore selected for full review (supplementary material, Appendix S1) of which 47 were then excluded from the meta-analysis because they were cohort studies (n = 18) or review articles (n = 11), or the data published was not extractable from the article or suitable for inclusion within the meta-analysis (n = 18). There were multiple reasons for non-inclusion in the meta-analysis (supplementary material, Appendix S1); in several studies, cut-off points for the diagnosis of anxiety/depression were used and the data were presented as odds ratios of having these conditions rather than presenting mean scores as a continuous scale. Others used scales that included assessment of anxiety and/or depression as part of a larger assessment of quality of life or used interviews or psychometric testing to assess psychological wellbeing rather than symptom questionnaires. Some studies assessed stress or distress levels rather than anxiety/depression and hence were not suitable for inclusion. Where appropriate the authors were contacted to ascertain information for inclusion in the analysis.
Twelve of the included studies provided data for the meta-analysis assessing the link between HG and depression. 12, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] For the meta-analysis of HG and anxiety, ten of these studies provided data; 12, 23, 25, 26, [28] [29] [30] [31] [32] [33] ; Hizli et al. and Aksoy et al. did not use anxiety scales in women with HG. 24, 27 Details of included studies are found in Table 1 . Only one study 34 specifically assessed symptoms of PTSD in women with HG but this was a cohort study (not casecontrol) and therefore meta-analysis was not possible. A further study 35 assessed the risk of recurrent HG in women reporting symptoms of PTSD following HG in their initial pregnancy and therefore did not fulfil our inclusion criteria.
The summary flow chart of the selection process is shown in Figure 1 .
Quality assessment of studies
The results of methodological assessment using the Newcastle-Ottawa scoring system are shown in Table 2 . 18 According to this scoring system, three studies were assessed to have a high risk of bias, 12, 25, 31 eight had a medium risk of bias 23, [26] [27] [28] [29] [30] 32, 33 and one 24 had a low risk of bias.
Description of studies and participants
Eight of the twelve studies assessed populations of women in Turkey, [23] [24] [25] [26] [27] 29, 32, 33 two assessed populations in Ireland 12, 30 and one each assessed populations in the USA 31 and the UK. 28 Several different scales were used to assess symptoms of anxiety and depression. The most commonly used scales were the Beck Depression Inventory, 36 used in six papers [23] [24] [25] 27, 32, 33 and the Beck Anxiety Inventory, 37 which was used in three studies 23, 32, 33 Other scales used were the Edinburgh Postnatal Depression Scale, 38 the Hospital Anxiety and Depression Scale 39 and the Spielberger Anxiety Index. 40 Three studies performed structured interviews with participants 24, 30, 31 whereas in the remainder, women carried out questionnaire assessments independently. Two studies [28] [29] [30] were subgroup analyses looking at women with HG as part of larger studies. King et al. assessed women with HG as part of a wider study looking at the psychological effects of 12 Simpson et al. assessed women with HG in the antenatal and postnatal period; the HG and control populations were not consistent as only a small proportion of those being assessed in the antenatal period went on to participate in the postnatal study with the other participants recruited de novo. 31 To maintain consistency with other studies, only the results from the earlier gestation and antenatal assessments were used for meta-analysis. From the remaining studies, four specified that psychological assessment was performed in the first trimester, 23, 24, 27, 32 three specified timings before 20 weeks of gestation 29, 31, 33 and two others reported that assessment was performed in the antenatal period without specifying gestation. 25, 26 King et al. assessed women in the third trimester. 28 There was variance in the selection criteria used for cases. Eight studies specified HG requiring admission as the main eligibility criterion. 12, 23, 24, 26, 27, [31] [32] [33] Of these, five gave specific criteria for admission based on frequency of vomiting, ketonuria, electrolyte disturbance and weight loss. 23, 24, 26, 27, 32 McCarthy et al. included women receiving outpatient treatment and classified women requiring admission as having 'severe HG'; when compared with the controls, the difference in mean scores assessing anxiety and depression symptoms were more marked in this group compared with the 'all hyperemesis' group. 30 One study, Koken et al., used the Rhodes scoring system to stratify symptoms of nausea and vomiting. 20, 29 This scale was originally designed to assess nausea and vomiting in patients with cancer. Those classified as having 'severe' symptoms were taken to represent women with HG. For the control groups the main stipulation of all studies was that these Excluded after full article review:
• Cohort study n = 18
• Review article n = 11
• Data not extractable or data not suitable for meta-analysis n = 18
Articles chosen for inclusion n = 12
• HG and depression n = 12
• HG and anxiety n = 10
Manual checking of citation lists n = 6 Figure 1 . Search summary.
women did not have significant symptoms of nausea and vomiting. This was based on self-reporting in all studies except that of Koken et al., who again used the Rhodes score to determine the control group constituting women with no symptoms of nausea and vomiting. 29 Five of the studies excluded women with pre-existing psychological conditions. 23, 24, 26, 27, 32 Of the other seven studies, four assessed levels of pre-existing psychological illness in both groups; 12 12, 33 Kender et al. reported that women in the HG group had a significantly higher incidence of family history of psychological illness. 33 There were no consistent (found in more than one study) independent variables identified to predict depression or anxiety. Measured variables included age, gestation, gravity/parity, BMI, educational level and socio-economic status.
McCarthy et al. found that women with HG were younger and more likely to be non-Caucasian. 30 Ezberci et al. found that the educational level in their HG group was higher than that of the control group. 26 All other studies identified no significant difference in the variables they assessed. In one study by Hizli et al. a sub-group analysis of depressed women in the HG group was performed; in these women the authors identified that there was evidence of poor social and family interaction compared with the non-depressed HG group. 27 
Association between HG and depression
For this analysis we compared 786 women with HG to 3965 controls without significant nausea and vomiting. Meta-analysis demonstrated a very large effect with significantly higher depression scale scores in women with HG (SMD 1.22; 95% CI 0.80-1.64; P ≤ 0.01). This SMD can be transformed to an approximate odds ratio of 9.12 (95% CI 4. 26-19.49) . 21 The Forest plot showing the overall association of HG with depression is shown in Figure 2 . We found significant heterogeneity (I 2 = 94%; P ≤ 0.00001) in this analysis.
Association between HG and anxiety
For this analysis we compared 508 women with HG to 3673 controls. Meta-analysis demonstrated a large effect with significantly higher anxiety scale scores in women with HG (SMD 0.86; 95% CI 0.53-1.19; P ≤ 0.01). This SMD can be transformed to an approximate odds ratio of 4.76 (95% CI 2.61-8.67). The Forest plot showing overall association of HG with anxiety is shown in Figure 3 . We again found significant heterogeneity but to a lesser extent than with the depression analysis (I 2 = 86%; P ≤ 0.00001). We wished to explore the possible reasons for this heterogeneity, but did not identify any studies stratifying the results for any of our above-mentioned confounding factors and hence were unable to perform a stratified metaanalysis.
Association between HG and post-traumatic stress disorder
A single study was identified that directly assessed the association between HG and PTSD. In this study by Christodoulou-Smith et al. women with HG were recruited through a support website and asked to complete a questionnaire in the postnatal period assessing the three categories of PTSD; re-experiencing, avoidance and hyper-arousal. 34 Eighteen percent (68/377) of participants fulfilled the full criteria for PTSD. 34 A control group was not used for this element of the study. A further study by Magtira et al. looked at recurrence rates of HG in women who reported symptoms of PTSD following their initial pregnancy affected by HG and so indirectly reported on the rate of PTSD in women suffering HG. 35 In keeping with the Christodoulou-Smith et al. study, up to 18% of women with HG fulfilled the full criteria for PTSD. 35 There did not appear to be an increased risk of HG recurrence in those women fulfilling the full stress criteria. Given the absence of case-control data in this area, meta-analysis was not possible.
Discussion
Main findings
This is the first meta-analysis to address the association between HG and psychological disease. It demonstrates clearly a strong link between HG and significant psychological morbidity, with statistically significantly higher depression and anxiety scale scores in women with HG compared with controls.
The analysis demonstrated a relatively high level of heterogeneity, which is considered to be a result of multiple factors. No independent variables were identified in relation to depression or anxiety. Meta-analysis of HG associated with PTSD was not possible due to a lack of case-control data.
Strengths and limitations
The main strengths of this study are that the included studies used validated tools for diagnosing depression and anxiety and as such the results highlight an area of real clinical significance beyond the purely physical HG disease process.
The findings of this meta-analysis are limited by methodological assessment of the papers included. The main source of potential bias appears to be in case selection. The key issue here is the lack of widely accepted diagnostic criteria for HG meaning that case selection was varied and open to interpretation. The MeSH terms used for the initial search were required as keywords in the returned articles. These keywords were also searched within the title and abstract, but we accept that there may have been a small number of papers studying other aspects of HG/NVP which had psychological illness as a secondary outcome reported only in the manuscript.
The degree of heterogeneity reported in this analysis is also a significant limitation. It is accounted for by multiple factors including: type of psychological assessment used, selection and definition of cases/controls (particularly definition of HG) and timing of assessment. Given the nature of this type of research and the differing participants and methodology used, one must accept that a meta-analysis to combine findings will be limited by heterogeneity. However, it is important to point out that despite the heterogeneity, the estimates consistently associated HG with psychological morbidity and we found no studies demonstrating a protective effect of HG. The strength of association varies, but all are positive and this consistency increases our confidence in the results.
The generalisability of the findings may be limited by the populations studied. Most of the women were of Turkish origin, but it is not possible to assess from the literature whether there is a link with ethnicity or cultural variation in the strength of association. The authors of these papers reported the same incidence of HG overall (0.3-2%) and there did not appear to be any duplicate reports of studies, as all the articles were published from different units in Turkey. In assessment of all tabulated articles that were systematically reviewed, there did not appear to be an overrepresentation of Turkish studies.
Interpretation
We have found strong evidence for an association between HG and both anxiety and depression. The findings support a shift in the clinical approach to HG, with more focus needed on supporting women with the condition and offering treatment for psychological morbidity where required. We must also consider that if the relationship is causal then improvement in the efficacy of therapeutic interventions for vomiting might also be beneficial at preventing anxiety and depression. Evidence regarding the efficacy of current treatment of NVP is limited. 42 Changing the attitudes of healthcare workers by disseminating the association shown here is of equal importance. Several studies have highlighted that women with HG feel unsupported, isolated and stigmatised by healthcare professionals, commonly being labelled as 'problem patients'. [43] [44] [45] Specialist hyperemesis clinical services other than the immediate emergency hospital treatment protocols are not readily available to support women with the condition following discharge from hospital. Consideration should be given to the development of designated HG care teams providing follow-up services and open access to advice and support.
There is evidence to suggest that other aspects of psychological wellbeing are also affected by HG including selfesteem, quality of life and stress levels. 26, 46, 47 Further to this, women with HG have reported significantly higher rates of breastfeeding problems, marital problems and financial difficulties. 30, 34 Although it is difficult to ascertain the true number, it is thought that a significant proportion of women with HG consider termination of pregnancy due to their symptoms. 48, 49 There are mixed reports on the longevity of psychological morbidity associated with HG. Tan et al. found that women with HG demonstrated a 'very strong rebound in psychological wellbeing after physical recovery', 50 suggesting that some of the effects may be temporary. Conversely however, Poursharif et al. found that the psychological fall out from HG was long lasting and indeed still evident in the postnatal period with women quoting for example that they were unable to 'forget how sick they were' and many adamant they would or could not have a further pregnancy due to their experience. 44 Kramer et al. assessed women at two stages in pregnancy and found that ongoing NVP was associated with a higher magnitude of psychological morbidity. 51 We did not aim in this study to address the question of whether HG is a cause or effect of psychological illness, rather to confirm the association between the two disorders. It is very difficult to prove the direction of effect and clinically, the association may facilitate identification of those women requiring more support during and after pregnancy regardless of the underlying mechanism. The majority of included studies did indeed exclude women with a history of psychological illness, which would seem to support the theory that psychological morbidity occurs as a result of HG rather than being an aetiological factor. However, a history of mental health disorders was largely based on self-reporting and baseline mental health assessment was not an option as women had already developed HG at the time of recruitment. Seng et al. analysed insurance data records and found that in a small subset of women who developed HG, psychiatric illness was a predisposing factor 52 and Chou et al. found that women at risk of poor maternal psychosocial adaption had not planned their pregnancies and tended to experience severe NVP. 53 In both of these studies methodological flaws are evident and at present there are no good data supporting a link between pre-existing psychological morbidity and the development of HG. [46] [47] [48] [49] [50] [51] [52] 
Conclusion
In this systematic review and meta-analysis, the first to assess the psychological morbidity associated with HG, we have shown both a statistical and clinically relevant higher prevalence of both anxiety and depression in women suffering with HG compared with controls without significant NVP. These associations may extend beyond the cessation of physical symptoms and into the postnatal period. Although data are limited, PTSD also appears prevalent in women who have suffered HG. Current evidence suggests that treatments for physical symptoms are of limited benefit in controlling nausea and vomiting, 42 which means that supportive care is of paramount importance. We conclude that there is now an urgent requirement to reappraise our clinical approach to HG to incorporate recognition and where appropriate therapeutic intervention for both physical and psychological morbidity.
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